Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 622

    1.

    Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.

    McMahon BJ, Holck P, Bulkow L, Snowball M.

    Ann Intern Med. 2001 Nov 6;135(9):759-68.PMID: 11694101 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.

    Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.

    J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. Epub 2009 Jun 17.PMID: 19535774 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hepatitis B e antigen and the risk of hepatocellular carcinoma.

    Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ; Taiwan Community-Based Cancer Screening Project Group.

    N Engl J Med. 2002 Jul 18;347(3):168-74.PMID: 12124405 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Summaries for patients. Outcomes of chronic infection with hepatitis B virus.

    [No authors listed]

    Ann Intern Med. 2001 Nov 6;135(9):1. No abstract available. PMID: 11759635 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.
    6.

    The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.

    Alward WL, McMahon BJ, Hall DB, Heyward WL, Francis DP, Bender TR.

    J Infect Dis. 1985 Apr;151(4):604-9.PMID: 2982971 [PubMed - indexed for MEDLINE]Related articles

    7.

    Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period.

    Bortolotti F, Jara P, Crivellaro C, Hierro L, Cadrobbi P, Frauca E, Camarena C, De La Vega A, Diaz C, De Moliner L, Noventa F.

    J Hepatol. 1998 Aug;29(2):184-90.PMID: 9722198 [PubMed - indexed for MEDLINE]Related articles

    8.

    Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F.

    Livingston SE, Simonetti JP, Bulkow LR, Homan CE, Snowball MM, Cagle HH, Negus SE, McMahon BJ.

    Gastroenterology. 2007 Nov;133(5):1452-7. Epub 2007 Aug 2.PMID: 17920063 [PubMed - indexed for MEDLINE]Related articles

    10.

    Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.

    Tsuchie H, Kurimura O, Tamura I, Shimase K, Kaneto E, Kurimura T, Tsuda F, Mayumi M.

    Biken J. 1984 Dec;27(4):169-76.PMID: 6100353 [PubMed - indexed for MEDLINE]Related articles

    11.

    Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.

    Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD.

    Hepatology. 1998 Jul;28(1):231-6.PMID: 9657117 [PubMed - indexed for MEDLINE]Related articles

    12.

    Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

    Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH; REVEAL-HBV Study Group.

    JAMA. 2006 Jan 4;295(1):65-73.PMID: 16391218 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation]

    Bujanda L, García Bengoechea M, Cilla G, Gil I, yArenas JI.

    Rev Esp Enferm Dig. 1996 May;88(5):335-9. Spanish. PMID: 8764540 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers.

    McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP.

    Arch Intern Med. 1990 May;150(5):1051-4.PMID: 2158773 [PubMed - indexed for MEDLINE]Related articles

    15.

    Chronic hepatitis B virus infection in Asian countries.

    Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

    J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.PMID: 11197043 [PubMed - indexed for MEDLINE]Related articles

    16.

    Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

    Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF.

    Hepatology. 2002 Jun;35(6):1522-7.PMID: 12029639 [PubMed - indexed for MEDLINE]Related articles

    17.

    Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia.

    Mendy ME, McConkey SJ, Sande van der MA, Crozier S, Kaye S, Jeffries D, Hall AJ, Whittle HC.

    Virol J. 2008 Apr 16;5:49.PMID: 18416832 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).

    Zacharakis GH, Koskinas J, Kotsiou S, Papoutselis M, Tzara F, Vafeiadis N, Archimandritis AJ, Papoutselis K.

    J Med Virol. 2005 Oct;77(2):173-9.PMID: 16121378 [PubMed - indexed for MEDLINE]Related articles

    19.

    Clinical significance of serum HBeAg and HBV-DNA-specific values of virus replication in chronic hepatitis-B virus infection.

    Alagiozian-Angelova V, Alagiozian D, Antonov K, Krustev Z.

    Folia Med (Plovdiv). 1998;40(4):34-41.PMID: 10371797 [PubMed - indexed for MEDLINE]Related articles

    20.

    Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study.

    Bortolotti F, Guido M, Bartolacci S, Cadrobbi P, Crivellaro C, Noventa F, Morsica G, Moriondo M, Gatta A.

    Hepatology. 2006 Mar;43(3):556-62.PMID: 16496323 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data